← Leaderboards
Howard Lee Elford
Molecules For Health, Inc.
$529,673
Attributed
$529,673
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $154.1K · FY2008–09$200K$150K$100K$50K$0
'08
'09
Funding mix
By agency
NIH$529,673 · 3
By mechanism
R43$529,673 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Ribonucleotide Reductase”
- Joanne Stubbe · Massachusetts Institute Of Technology$10,830,963
- Daniel G. Nocera · Harvard University$9,029,105
- Michael Regnier · University Of Washington$7,786,680
- Lawrence Que · University Of Minnesota Twin Cities$7,487,200
- Donna S. Shewach · University Of Michigan At Ann Arbor$6,121,517
- Jeffrey S Chamberlain · University Of Michigan At Ann Arbor$5,225,126
Research focus
Ribonucleotide ReductaseLaboratory RatDrug Screening /EvaluationElectron Spin Resonance SpectroscopyFree Radical ScavengersAreaAntineoplasticsAnimal ModelAnti-Inflammatory AgentsBaseBiochemical PathwayBlood ClotBlood CoagulationBlood VesselsAngioplasty, Transluminal, Percutaneous CoronaryCardiotoxinCaliberArteriesCardiovascular FunctionCause Of DeathCell MotilityCell ProliferationCellsBypass
Grant awards (5)
Ribonucleotide Reductase Inhibitors for Restenosis$71,570
R43 · FY2009 · HL · contact PI
Ribonucleotide Reductase Inhibitors for Restenosis$154,128
R43 · FY2008 · HL · contact PI
Radical Scavengers for Brain Ischemia Reperfusion injury$100,000
R43 · FY2003 · NS
'Novel Cancer Drugs to Prevent Doxorubicin Toxicity'$96,208
R43 · FY2002 · CA
Novel Cancer Drugs to Prevent Doxorubicin Toxicity$107,767
R43 · FY2001 · CA